1117 related articles for article (PubMed ID: 8793654)
21. KBA.62: a useful marker for primary and metastatic melanomas.
Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L
Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
[TBL] [Abstract][Full Text] [Related]
22. Oral melanocytic lesions: differences in expression of HMB-45 and S-100 antigens in round and spindle cells of malignant and benign lesions.
Gazit D; Daniels TE
J Oral Pathol Med; 1994 Feb; 23(2):60-4. PubMed ID: 8164154
[TBL] [Abstract][Full Text] [Related]
23. Expression of Melan-A in Spitz, pigmented spindle cell nevi, and congenital nevi: comparative immunohistochemical study.
Evans MJ; Sanders DS; Grant JH; Blessing K
Pediatr Dev Pathol; 2000; 3(1):36-9. PubMed ID: 10644168
[TBL] [Abstract][Full Text] [Related]
24. Desmoplastic and spindle cell melanomas express protein markers of the neural crest but not of later committed stages of Schwann cell differentiation.
Huttenbach Y; Prieto VG; Reed JA
J Cutan Pathol; 2002 Oct; 29(9):562-8. PubMed ID: 12358815
[TBL] [Abstract][Full Text] [Related]
25. S100-positive spindle cells in scars: a diagnostic pitfall in the re-excision of desmoplastic melanoma.
Chorny JA; Barr RJ
Am J Dermatopathol; 2002 Aug; 24(4):309-12. PubMed ID: 12142609
[TBL] [Abstract][Full Text] [Related]
26. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study.
Longacre TA; Egbert BM; Rouse RV
Am J Surg Pathol; 1996 Dec; 20(12):1489-500. PubMed ID: 8944042
[TBL] [Abstract][Full Text] [Related]
27. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
Zubovits J; Buzney E; Yu L; Duncan LM
Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
[TBL] [Abstract][Full Text] [Related]
28. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
Orosz Z
Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
[TBL] [Abstract][Full Text] [Related]
29. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma.
Harris GR; Shea CR; Horenstein MG; Reed JA; Burchette JL; Prieto VG
Am J Surg Pathol; 1999 Jul; 23(7):786-94. PubMed ID: 10403301
[TBL] [Abstract][Full Text] [Related]
30. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors.
Steuhl KP; Rohrbach JM; Knorr M; Thiel HJ
Ophthalmology; 1993 Feb; 100(2):208-15. PubMed ID: 8437829
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical studies of conjunctival nevi and melanomas.
Jakobiec FA; Bhat P; Colby KA
Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
[TBL] [Abstract][Full Text] [Related]
32. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
33. Nerve growth and expression of receptors for nerve growth factor in tumors of melanocyte origin.
Bröcker EB; Magiera H; Herlyn M
J Invest Dermatol; 1991 May; 96(5):662-5. PubMed ID: 1850772
[TBL] [Abstract][Full Text] [Related]
34. Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma.
Ordóñez NG; Ji XL; Hickey RC
Am J Clin Pathol; 1988 Oct; 90(4):385-90. PubMed ID: 2459952
[TBL] [Abstract][Full Text] [Related]
35. Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.
Dorvault CC; Weilbaecher KN; Yee H; Fisher DE; Chiriboga LA; Xu Y; Chhieng DC
Cancer; 2001 Oct; 93(5):337-43. PubMed ID: 11668469
[TBL] [Abstract][Full Text] [Related]
36. Desmoplastic melanoma: an updated immunohistochemical analysis of 40 cases with a proposal for an additional panel of stains for diagnosis.
Plaza JA; Bonneau P; Prieto V; Sangueza M; Mackinnon A; Suster D; Bacchi C; Estrozi B; Kazakov D; Kacerovska D; Falconieri G; Suster S
J Cutan Pathol; 2016 Apr; 43(4):313-23. PubMed ID: 26661921
[TBL] [Abstract][Full Text] [Related]
37. Procollagen 1 and Melan-A expression in desmoplastic melanomas.
Leinweber B; Hofmann-Wellenhof R; Kaddu S; McCalmont TH
Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805
[TBL] [Abstract][Full Text] [Related]
38. NGFR (p75) expression in cutaneous scars; Further evidence for a potential pitfall in evaluation of reexcision scars of cutaneous neoplasms, in particular desmoplastic melanoma.
Otaibi S; Jukic DM; Drogowski L; Bhawan J; Radfar A
Am J Dermatopathol; 2011 Feb; 33(1):65-71. PubMed ID: 21178583
[TBL] [Abstract][Full Text] [Related]
39. P75 neurotrophin receptor expression in squamous cell carcinoma.
Anolik RB; Aung PP; Bhawan J
Am J Dermatopathol; 2015 Feb; 37(2):160-1. PubMed ID: 25321086
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
Hultgren TL; DiMaio DJ
J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
